Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Boric Acid vs Clotrimazole in Otomycosis
NCT04824261Unknown
- Sponsor
- Assiut University
- Start
- Jun 2021
- Primary completion
- May 2022
- Modality
- DNA Intercalators/Alkylators
01
Overview
Randomised trial of boric acid in otomycosis (2 arms), sponsored by Assiut University. Primary endpoint: Curative rate of otomycosis at 1 month. Status: unknown.
02
Drugs
boric acid
03
Conditions
otomycosis
Beyond the preview
Go deeper on NCT04824261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04824261.